First-year quality of life assessment of an intraarterial (radplat) versus intravenous chemoradiation phase III trial

Head and Neck

Volumn 31, Issue 1, 2009, Pages 77-84

  Ackerstaff, Annemieke H ^a   Balm, Alfons J M ^a   Rasch, Coen R N ^a   De Boer, Jan Paul ^a   Wiggenraad, Ruud ^b   Rietveld, Derk H F ^c   Gregor, R Theo ^d   Kröger, Robert ^a   Hilgers, Frans J M ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c Radiotherapy Institute Friesland   (Netherlands)

^d WAIKATO HOSPITAL   (New Zealand)

Author keywords

Aadvanced stage; Chemoradiation; Hhead and neck cancer; Intra arterial infusion; IV infusion; Quality of life

Indexed keywords

CISPLATIN; SODIUM THIOSULFATE;

ADULT; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATIGUE; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NECK PAIN; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SPEECH DISORDER; STICKY SALIVA; SURVIVAL RATE; TREATMENT DURATION; TUBE FEEDING; VOICE; VOMITING; WEIGHT REDUCTION; XEROSTOMIA;

ALCOHOL DRINKING; ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; FATIGUE; FEMALE; HEAD AND NECK NEOPLASMS; HEALTH BEHAVIOR; HEALTH STATUS INDICATORS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; NAUSEA; OROPHARYNGEAL NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; SMOKING; VOMITING; XEROSTOMIA;

EID: 58149494809     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20937     Document Type: Article

References (20)

1. Balm AJM, Ackerstaff AH, Hilgers FJM, Gregor RT, Bos KE. Psychological aspects of major head and neck surgery. Facial Plast Surg 1995;2:91-98.
2. Ackerstaff AH, Lindeboom JAH, Balm AJM, Kroon FHM, Tan IB, Hilgers FJM. Structured assessment of the consequences of composite resection. Clin Otolaryngol 1998;23:339-344.
3. de Graeff A, de Leeuw RJ, Ros WJG, Hordijk G-J, Blij-ham GH, Winnubst JAM. Long-term quality of life of patients with head and neck cancer. Laryngoscope 2000; 110:98-106.
4. List MA, Bilir SP. Functional outcomes in head and neck cancer. Semin Radiat Oncol 2004;14:178-189.
5. Ackerstaff AH, Hilgers FJM. Rehabilitation after head and neck surgery. In: Jones AS, Phillips DE, Hilgers FJM, editors. Diseases of the head and neck, nose and throat. London: Edward Arnold; 1998. pp 435-448.
6. Langius A, Björvell H, Lind MG. Functional status and coping in patients with oral and pharyngeal cancer before and after surgery. Head Neck 1994;16:559-568.
7. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. Lancet 2000;355:949-955.
8. Robbins KT, Vicario D, Seagren S, et al. Targeted supra-dose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg 1994;168:419-422.
9. Robbins KT. The evolving role of combined modality therapy in head and neck cancer. Arch Otolaryngol Head Neck Surg 2000;126:265-269.
10. Balm AJ, Rasch CR, Schornagel JH, et al. High-dose su-perselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck 2004;26:485-493.
11. Ackerstaff AH, Tan IB, Rasch CN, et al. Quality of life assessment after supradose selective intra-arterial cis-platin and concomitant radiation (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2002;128:1185-1190.
12. Rasch C, Balm A, Kroger R, et al. Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer, early results of a multi-institutional trial. Proceedings of the 2006 annual meeting and research workshop on the biology, prevention and treatment of head and neck cancer, Chicago, August 17-20, 2006 (abstract S016, p 84).
13. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.
14. Bjordal K, Hammerlid E, Ahlner-Elmquist M, et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer quality of life questionnaire-H&N 35. J Clin Oncol 1999;17:1008-1019.
15. List MA, Siston A, Haraf D, Schumm P, et al. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol 1999;17:1020-1028.
16. Epsteinn JB, Emerton S, Kolbinson DA, et al. Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 1999;21:1-11.
17. Nguyen NP, Moltz CC, Vos FP, et al. Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol 2004;15:383-88.
18. Logemann JA, Pauloski BR, Rademaker AW, et al. Xerostomia: 12 months changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck 2003;25:432-437.
19. Murry T, Madasu R, Martin A, Robbins KT. Acute and chronic changes in swallowing and quality of life following intraarterial chemoradiation for organ preservation in patients with advanced head and neck cancer. Head Neck 1998;20:31-37.
20. Pauloski BR, Rademaker AW, Logemann JA, et al. Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck 2002; 24:555-565.